NR

Nanu Ram Aggarwal

Active Director Director DIN 07056634
DIN 07056634 First appointment Mar 2015 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2015
Shareholding value •••• Premium profile

About Nanu Ram Aggarwal

Data last updated:

Nanu Ram Aggarwal is a Director at Medprio Life Sciences Private Limited (since 2015). The company operates in Healthcare. Medprio Life Sciences Private Limited reported revenue of ₹3.29 Cr (FY 2025).

DIN 07056634
Primary Designation Director
Industry Healthcare
First Appointment 09 Mar 2015
Oldest Company Age 11 yrs
Largest company Medprio Life Sciences Private Limited · ₹3.29 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Mar 20152015₹3.29 Cr (FY 2025)Active

Board colleagues of Nanu Ram Aggarwal

Directorship timeline

Open interactive timeline →
Medprio Life Sciences Private Limited
Premium access

Shareholding and investment profile for Nanu Ram Aggarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nanu Ram Aggarwal

Nanu Ram Aggarwal currently holds 1 directorship: Medprio Life Sciences Private Limited (Director, since 09 Mar 2015, revenue ₹3.29 Cr (FY 2025)).

Nanu Ram Aggarwal was first appointed on 09 Mar 2015 as Director at Medprio Life Sciences Private Limited.

The current boards of Nanu Ram Aggarwal's companies include Babita Bansal (Medprio Life Sciences Private Limited), Vikas Aggarwal (Medprio Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available